Article
Towards Stratified Medicine in Plasma Cell Myeloma.
International journal of molecular sciences - 21 Oct 2016
Egan Philip, Drain Stephen, Conway Caroline, Bjourson Anthony J, Alexander H Denis
Abstract excerpt
Plasma cell myeloma is a clinically heterogeneous malignancy accounting for approximately one to 2% of newly diagnosed cases of cancer worldwide. Treatment options, in addition to long-established cytotoxic drugs, include autologous stem cell transplant, immune modulators, proteasome inhibitors and monoclonal antibodies, plus further targeted therapies currently in clinical trials. Whilst treatment decisions are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
